BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37669948)

  • 1. Programmable RNA detection with CRISPR-Cas12a.
    Rananaware SR; Vesco EK; Shoemaker GM; Anekar SS; Sandoval LSW; Meister KS; Macaluso NC; Nguyen LT; Jain PK
    Nat Commun; 2023 Sep; 14(1):5409. PubMed ID: 37669948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmable RNA detection with CRISPR-Cas12a.
    Rananaware SR; Vesco EK; Shoemaker GM; Anekar SS; Sandoval LSW; Meister KS; Macaluso NC; Nguyen LT; Jain PK
    Res Sq; 2023 Feb; ():. PubMed ID: 36824842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmable RNA detection with CRISPR-Cas12a.
    Rananaware SR; Vesco EK; Shoemaker GM; Anekar SS; Sandoval LSW; Meister KS; Macaluso NC; Nguyen LT; Jain PK
    bioRxiv; 2023 Jan; ():. PubMed ID: 36778248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized protocols for the characterization of Cas12a activities.
    Martin L; Rostami S; Rajan R
    Methods Enzymol; 2023; 679():97-129. PubMed ID: 36682874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAM-free cascaded strand displacement coupled with CRISPR-Cas12a for amplified electrochemical detection of SARS-CoV-2 RNA.
    Shi K; Yi Z; Han Y; Chen J; Hu Y; Cheng Y; Liu S; Wang W; Song J
    Anal Biochem; 2023 Mar; 664():115046. PubMed ID: 36641031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulating the
    Fei X; Lei C; Ren W; Liu X; Liu C
    Anal Chem; 2023 Aug; 95(32):12169-12176. PubMed ID: 37531567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic Insights into the cis- and trans-Acting DNase Activities of Cas12a.
    Swarts DC; Jinek M
    Mol Cell; 2019 Feb; 73(3):589-600.e4. PubMed ID: 30639240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional DNA Regulated CRISPR-Cas12a Sensors for Point-of-Care Diagnostics of Non-Nucleic-Acid Targets.
    Xiong Y; Zhang J; Yang Z; Mou Q; Ma Y; Xiong Y; Lu Y
    J Am Chem Soc; 2020 Jan; 142(1):207-213. PubMed ID: 31800219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic Incorporation of Two ssDNA Activators Enhances the Trans-Cleavage of CRISPR/Cas12a.
    Li Q; Song ZL; Zhang Y; Zhu L; Yang Q; Liu X; Sun X; Chen X; Kong R; Fan GC; Luo X
    Anal Chem; 2023 Jun; 95(23):8879-8888. PubMed ID: 37252785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a.
    Swarts DC; van der Oost J; Jinek M
    Mol Cell; 2017 Apr; 66(2):221-233.e4. PubMed ID: 28431230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating CRISPR-Cas12a with a crRNA-Mediated Catalytic Network for the Development of a Modular and Sensitive Aptasensor.
    Shu X; Zhang D; Li X; Zheng Q; Cai X; Ding S; Yan Y
    ACS Synth Biol; 2022 Aug; 11(8):2829-2836. PubMed ID: 35946354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimuli-responsive incremental DNA machine auto-catalyzed CRISPR-Cas12a feedback amplification permits ultrasensitive molecular diagnosis of esophageal cancer-related microRNA.
    Li H; Wang Y; Wan Y; Li M; Xu J; Wang Q; Wu D
    Talanta; 2024 May; 271():125675. PubMed ID: 38245957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cascade Signal Amplification Based on Dynamic DNA Nanodevices and CRISPR/Cas12a Trans-cleavage for Highly Sensitive MicroRNA Sensing.
    Li X; Zhang D; Gan X; Liu P; Zheng Q; Yang T; Tian G; Ding S; Yan Y
    ACS Synth Biol; 2021 Jun; 10(6):1481-1489. PubMed ID: 34011151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Cme and Yme thermostable Cas12a orthologs.
    Fuchs RT; Curcuru JL; Mabuchi M; Noireterre A; Weigele PR; Sun Z; Robb GB
    Commun Biol; 2022 Apr; 5(1):325. PubMed ID: 35388146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A universal CRISPR/Cas12a nucleic acid sensing platform based on proximity extension and transcription-unleashed self-supply crRNA.
    Tian G; Zhang D; Wang Y; Hu T; Lin Y; Wang Y; Cheng W; Xia Q
    Anal Chim Acta; 2021 Sep; 1176():338755. PubMed ID: 34399899
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kohabir KAV; Nooi LO; Brink A; Brakenhoff RH; Sistermans EA; Wolthuis RMF
    CRISPR J; 2023 Apr; 6(2):127-139. PubMed ID: 36637878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three novel Cas12a orthologs with robust DNA cleavage activity suitable for nucleic acid detection.
    Liu X; Qiu X; Han L; Yue Y; Xu S; Li F; Yao J; Sun L; Li Z
    Gene; 2023 Feb; 852():147055. PubMed ID: 36400115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas12a Powered DNA Framework-Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis.
    Su J; Ke Y; Maboyi N; Zhi X; Yan S; Li F; Zhao B; Jia X; Song S; Ding X
    Small Methods; 2021 Dec; 5(12):e2100935. PubMed ID: 34928030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric CRISPR enabling cascade signal amplification for nucleic acid detection by competitive crRNA.
    Moon J; Liu C
    Nat Commun; 2023 Nov; 14(1):7504. PubMed ID: 37980404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Basis for the Inhibition of CRISPR-Cas12a by Anti-CRISPR Proteins.
    Zhang H; Li Z; Daczkowski CM; Gabel C; Mesecar AD; Chang L
    Cell Host Microbe; 2019 Jun; 25(6):815-826.e4. PubMed ID: 31155345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.